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INTRODUCTION
AN ideal method of induction of labour should be simple, safe, effective and non-
invasive thereby increasing the acceptance by the patient and reducing the risks
associated with amniotomy. The unripe cervix has always been a problem but in
recent years prostaglandin E2hasbeen shown to have adirect effect onthis, possibly
by modifying the glyco-amnio glycans in the cervical ground substance.
Over the past few years prostaglandin has beenused withvarying success ratesby
differing routes, however its use intravenously and orally has been limited by the
side-effects of gastro-intestinal disturbance and local cellulitis at the venopuncture
site. Prostaglandin has beenadministered as ajelextra-amniotically andas apessary
with encouraging results reported intherecentmedical literature. Work fromQueen
Charlotte's Hospital by Shepherd et al. suggests that induction of labour using a
3 mg pessary can be a highly efficient and acceptable procedure. However, it was
noted by these authors that a multiparous patient with a favourable cervix had
vigorous uterine contractions upon insertion ofthe pessary. Uterine hypertonus had
been noted by us in a higher percentage of cases while using a 3 mg pessary even
when the cervix was not particularly favourable. Gordon-Wright and Elder have
demonstrated that there is rapid systemic absorption of prostaglandin after
administration ofthe drug in pessary form with a maximum effect in two hours and
that the systemic level can remain high for up to six hours-this may explain the
cases ofhypertonus.
In 1980 Liggins had shown that small amounts of prostaglandins vaginally are
also successful in inducing labour-the dose he used was 1/15th of the Queen
Charlotte dose-0.2 mg without the risk of hypertonus. This paper presents the
results of a study carried out at the Jubilee Maternity Hospital, Belfast comparing
3 mg pessaries on two occasions with lower dose pessaries (2.0 mg and 0.5 mg)
administered more frequently in an effort to rationalise the use of this drug and
minimise the potential hazard ofhypertonic uterine action.
PATIENTS AND METHODS
From the 1st May 1980 all patients at the Jubilee Maternity Hospital requiring
induction had prostaglandin pessaries with the exception of four categories:-
(1) Patient or consultant objection
(2) The cervix greater than 3 cms dilated
(3) Patients thought to be at risk of developing fetal distress in labour
(4) The presence ofintrauterine death.
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As prostaglandin has a short half life the pessaries were made up in our local
pharmacy using a glyceride base (Witepsol)-these have a ward refrigerator life of5
days. In all, 300 patients were included in the trial and 70 per cent ofthe inductions
were carried out for hypertensive states or post-maturity. The others were carried
out for various other medical and obstetrical indications.
The 300patients were randomly allocated into one ofthreegroups of 100. As seen
in Table I the weaker pessaries were inserted more frequently and iflabour had not
intervened in the stipulated time (24 hours Group A; 48 hours Groups B & C)
induction of labour was carried out using amniotomy and syntocinon infusion.
TABLE I
Pessary dose and time ofadministration
GROUP A (n=100) B (n=100) C (n=100)
PESSARY STRENGTH 3 mg 2 mg 0.5 mg





MAX. NO. 2 6 10
Prior to the insertion of the first pessary the favourability for induction was
assessed by means of a modified Bishop score. This takes into account four features
regarding the cervix, namely dilatation, length, consistency and position which with
the station of the head one can allocate a maximum score of 12 points. A score
above 8 is regarded as "favourable" and less than 5 "unfavourable".
After insertion of a pessary the patient remained supine for one hour and
thereafter was able to be up and about the antenatal ward. Transfer to the labour
ward occurred when the cervix was 4 cms dilated and some patients had
augmentation with Syntocinon at the discretion ofthe Labour Ward Staff. Internal
monitoring of labour was used in all but eight of the cases.
RESULTS
There was no significant difference in the three groups with regard to maternal
age, weight, height or parity. The gestational age was found to be comparable in all
three groups-just over term.
The mean Bishop scores were 5.8, 5.7 and 5.5 respectively. When the outcome of
each group was analysed the induction delivery intervals were 15.5 hours, 14.7 hours
and 29.5 hours respectively-the 0.5 mg pessaries taking significantly longer
(P > 0.001). There were significantly fewer patients in Group B (5) who failed to go
into established labour after the stipulated time compared with Group A (17) and
Group C (24). Of those who went into spontaneous labour with the pessaries
14247 per cent in Group A, 38 per cent in Group B and 53 per cent in Group C required
augmentation with Syntocinon infusion during labour.
Table II demonstrated the average amounts of prostaglandin used in each group.
Signif'icantly less prostaglandin was used in Group C. However, as mentioned above
the induction-delivery interval was greatly increased and 24 per cent failed to
become established in labour after 48 hours.
TABLE II
Average amounts ofprostaglandin required to induce labour
A (3 mg) B (2 mg) C (0.5 mg)
Average number of pessaries 1.6 2.0 5.6
Average PGE2 (mg) 4.8 4.0 2.5
TABLE III
Mode ofDelivery
A (3 mg) B (2 mg) C (0.5 mg)
Normal 81 82 78
Breech 1
Assisted delivery 9 12 11
Caesarean section 9 6 11
TOTAL 100 100 100
There was no significant difference in the incidence of occipito-posterior position
in labour or in the assisted delivery rate. Fewer Caesarean sections were performed
in Group B. The number of assisted and operative deliveries carried out for fetal
distress was similar in each group (Group A nine; Group B six; Group C eight).
BABIES
Apgar scores were similar in each group with four babies with an initial Apgar
score less than 6-three in Group A and one in Group C.
Group A:-Fetal distress: forceps delivery
-Fetal distress: Caesarean section (hypertonus)
-Breech presentation
Group C:-Dysmature fetus
All babies subsequently progressed satisfactorily and there were no perinatal
deaths in this selected group of patients.
PATIENT ACCEPTABILITY
In general, the patients were enthusiastic about this method of induction using
terms like "more natural" to describe the experience and all multiparae who had
labour induced before by amniotomy and syntocinon preferred this method.
143Six patients of the 0.5 mg group complained of stinging in the vagina. This has
been shown inother centres to be associated with monilial vaginitis, however we had
no data to prove this in our series.
Vigorous labour was noted by eight patients in the 3 mg group and two of these
cases had definite hypertonus. The first was a para one aged 33 years with a
modified Bishop score of two in whom induction was being carried out for
prolonged pregnancy. Two hours after insertion of a 3 mg pesary persistent
bradycardia in association with a tonic uterine contraction was noted. Preparations
were made for delivery by Caesarean section and 20 minutes later, just before
operation, it was noted that the cervical dilatation was unchanged and that the tonic
uterine contraction persisted. At Caesarean section a male fetus was born weighing
2840 g with an Apgar score of four at one minute and ten at five minutes. The
second patient was a para oneaged 34 years whose initial Bishop score was four and
in whom the second 3 mg prostaglandin pessary was inserted because the cervical
dilatation was unchanged. Over the next hour very strong uterine contractions
developed and continued until the patient was delivered one and a half hours later.
The baby weighed 3280 g and had an Apgar score of five at one minute and nine at
five minutes. DISCUSSION
Vaginal administration of prostaglandin E2 pessaries has been shown to improve
the outcome ofinduced labour in other centres where it has been used effectively for
routine induction oflabour. However, the potential advantages which have been put
forward enthusiastically have to be balanced by the problems associated with the
instability of the preparations used and the variable and sometimes very rapid
absorption of prostaglandin. This study was undertaken to determine whether
repeated low doses of prostaglandin might be as effective as a higher dose in
inducing labour, thereby reducing the risk of unduly rapid progress in labour.
The results suggest that the lowest dose pessary (0.5 mg) given in the manner
described is not as effective as one six times this strength (3 mg). Although the low
dose pessary was successful in inducing labour in 73 per cent ofwomen in this series
(similar to thatreported byLiggins), the number ofinduction failures after48 hours
with this pessary was much higher than when the high dose was used. Also, the
overall induction-delivery interval was significantly longer and a small number of
patients required excessive analgesia. Because of these factors, the lowest dose
pessary cannotberecommended. Whilethe 3 mg pessary is veryeffective in inducing
labour we cannot endorse its use because of the unpredictable risk of vigorous
labour and hypertonus encountered in our patients with the consequent risks toboth
mother and fetus.
The compromise seems to lie with the 2 mg pessary administered four hourly-
where one finds the lowest mean induction-delivery interval of 14.7 hours with a
significantly lower Caesarean section rate of 6 per cent in the absence ofhypertonic
uterine action. The mean number of pessaries used in this group is also very low at
two. From the practical point of view we now use 2.0 mg pessaries in the manner
described routinely in all patients requiring induction of labour where the cervix is
less than 3 cms dilated.
While the pessaries are expensive (£5 each) and have a short shelf life, the
advantages in our experience seem to outweigh the disadvantages. This easily-
144administered, non-invasive method of induction, which ensures the integrity ofthe
membranes, in this dose is relatively free from side-effects and is very acceptable by
both staff and patient alike.
Itis more physiological inits actionandwehavehalvedtheCaesarean sectionrate
in induced primigravidas since the method was introduced, bringing the overall
hospital rate to under 10 per cent. Theproblems ofinducing labourwherethecervix
is unfavourable have been greatly reduced at no apparent risk to mother or fetus.
We do accept that the use of this drug must be carefully monitored, and we are
keeping the matter under constant review.
SUMMARY
Prostaglandin E2 has been used by varying routes over the past decade to induce
labour. Recently, vaginal pessaries have been used as a convenient non-invasive
method of inducing labour. However, the risk of uterine hypertonus is still
encountered.
A randomised trial is described which aims to ascertain the most effective pessary
strength and regimen, while reducing undesirable side effects to a minimum. Our
experience suggests that 2 mg pessaries four hourly is the most safe and effective
method.
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